HK1192880A1 - 安貝生坦製備的改進過程 - Google Patents

安貝生坦製備的改進過程

Info

Publication number
HK1192880A1
HK1192880A1 HK14105259.9A HK14105259A HK1192880A1 HK 1192880 A1 HK1192880 A1 HK 1192880A1 HK 14105259 A HK14105259 A HK 14105259A HK 1192880 A1 HK1192880 A1 HK 1192880A1
Authority
HK
Hong Kong
Prior art keywords
ambrisentan
preparation
improved process
improved
Prior art date
Application number
HK14105259.9A
Other languages
English (en)
Inventor
Kaushik Babubhai Sata
Bipin Pandey
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of HK1192880A1 publication Critical patent/HK1192880A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK14105259.9A 2009-07-10 2012-10-11 安貝生坦製備的改進過程 HK1192880A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1626MU2009 2009-07-10
IN2233MU2009 2009-09-25
IN462MU2010 2010-02-19

Publications (1)

Publication Number Publication Date
HK1192880A1 true HK1192880A1 (zh) 2014-09-05

Family

ID=43297159

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12110072.6A HK1169396A1 (en) 2009-07-10 2012-10-11 Improved process for the preparation of ambrisentan and novel intermediates thereof
HK14105259.9A HK1192880A1 (zh) 2009-07-10 2012-10-11 安貝生坦製備的改進過程

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK12110072.6A HK1169396A1 (en) 2009-07-10 2012-10-11 Improved process for the preparation of ambrisentan and novel intermediates thereof

Country Status (6)

Country Link
US (1) US8962832B2 (zh)
EP (2) EP2451786B1 (zh)
JP (1) JP5531097B2 (zh)
ES (2) ES2575000T3 (zh)
HK (2) HK1169396A1 (zh)
WO (1) WO2011004402A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2309996A2 (de) * 2008-08-11 2011-04-20 Ratiopharm GmbH Amorphes ambrisentan
CN102219748B (zh) * 2011-05-04 2014-05-07 天津市医药集团技术发展有限公司 无定型安贝生坦及其制备方法
CN102276536B (zh) 2011-06-10 2015-04-29 中国科学院化学研究所 一种光学纯的(+)-安倍生坦和光学纯的(+)-达芦生坦的制备方法
CN102887861B (zh) * 2011-07-18 2015-04-15 天津市医药集团技术发展有限公司 一种安贝生坦新晶型及其制备方法
BR112014009437A2 (pt) * 2011-10-19 2017-04-11 Cipla Ltd processo para preparar um composto, composto e uso de um composto
CN103420811B (zh) * 2012-05-18 2015-04-15 上海医药工业研究院 用于制备安立生坦的中间体化合物及其制备方法、以及安立生坦的制备
US9533960B2 (en) 2012-06-29 2017-01-03 Kern Pharma, S.L. Preparation process of carboxylic acid derivatives and intermediates thereof
CN103524425A (zh) * 2012-07-04 2014-01-22 天津药物研究院 一种安立生坦的晶型v及其制备方法和应用
WO2014139087A1 (zh) * 2013-03-12 2014-09-18 江苏康缘药业股份有限公司 一种手性2-[(4,6-二甲基嘧啶-2-基)氧基]-3-甲氧基-3,3-二苯基丙酸的消旋化方法
CN104515816B (zh) * 2013-09-29 2016-04-20 天津药物研究院 一种安立生坦原料及制剂有关物质的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4313412A1 (de) * 1993-04-23 1994-10-27 Basf Ag 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
ID25620A (id) * 1997-09-04 2000-10-19 Basf Ag Turunan-turunan asam karboksilat baru, pembuatannya dan penggunaannya sebagai campuran reseptor antagonis et a/et b
DE19850301A1 (de) 1998-10-30 2000-05-04 Basf Ag Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren
DE19858779A1 (de) * 1998-12-18 2000-06-21 Basf Ag Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
DE19933164A1 (de) * 1999-07-20 2001-01-25 Basf Ag Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten
WO2008097468A2 (en) 2007-02-02 2008-08-14 Concert Pharmaceuticals, Inc. Selective endothelin type-a antagonists
EP2309996A2 (de) 2008-08-11 2011-04-20 Ratiopharm GmbH Amorphes ambrisentan
WO2010070658A2 (en) * 2008-11-05 2010-06-24 Msn Laboratories Limited Improved process for the preparation of endothelin receptor antagonists
WO2010091877A2 (en) * 2009-02-13 2010-08-19 Ratiopharm Gmbh Process for producing ambrisentan

Also Published As

Publication number Publication date
HK1169396A1 (en) 2013-01-25
ES2575000T3 (es) 2016-06-23
US8962832B2 (en) 2015-02-24
WO2011004402A2 (en) 2011-01-13
ES2462065T3 (es) 2014-05-22
JP5531097B2 (ja) 2014-06-25
EP2712865A1 (en) 2014-04-02
EP2451786B1 (en) 2014-01-22
EP2712865B1 (en) 2016-03-16
EP2451786A2 (en) 2012-05-16
US20120184573A1 (en) 2012-07-19
WO2011004402A3 (en) 2011-03-10
JP2012532863A (ja) 2012-12-20

Similar Documents

Publication Publication Date Title
ZA201202504B (en) Process for the preparation of calcobutrol
HK1192880A1 (zh) 安貝生坦製備的改進過程
PL2387566T3 (pl) Sposób przygotowania rosuwastatyny
SI2151428T1 (sl) Postopek za pripravo agomelatina
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
HUE066392T2 (hu) Eljárás fluoralkil-fluorformiát elõállítására
IL214906A (en) A process for making Iwan
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
IL219138A0 (en) Process for the preparation of 4-sulfinyl-pyrazole derivatives
SI2151429T1 (sl) Postopek za pripravo agomelatina
EG26332A (en) Process for the preparation of benzonoprons
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
IL217139A0 (en) Process for the preparation of arylpyridinyl compounds
IL215022A0 (en) Novel process for the preparation of enaminocarbonyl compounds
PT2390246T (pt) Processo para a preparação de aminaftona
IL217460A0 (en) Novel process for the preparation of 4-aminobut-2-enolides
GB0905895D0 (en) Process for the preparation of chalcogenone compounds
ZA201201657B (en) Processes for the preparation of vardenafil
PL2598504T3 (pl) Sposób otrzymywania dimiracetamu
IL211382A0 (en) Process for the preparation of ethanedinitrile
IL220160A (en) A process for the preparation of defrasirox
PL389568A1 (pl) Sposób otrzymywania 2-metyloglicydolu
IL224304A (en) A process for making dichlorobulben
PL388516A1 (pl) Sposób wytwarzania nanokompozytu

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200714